1. Academic Validation
  2. NG2 glia protect against prion neurotoxicity by inhibiting microglia-to-neuron prostaglandin E2 signaling

NG2 glia protect against prion neurotoxicity by inhibiting microglia-to-neuron prostaglandin E2 signaling

  • Nat Neurosci. 2024 May 27. doi: 10.1038/s41593-024-01663-x.
Yingjun Liu 1 Jingjing Guo 2 Maja Matoga 2 Marina Korotkova 3 4 Per-Johan Jakobsson 3 4 Adriano Aguzzi 5
Affiliations

Affiliations

  • 1 Institute of Neuropathology, University of Zurich, Zurich, Switzerland. yingjun.liu@bsse.ethz.ch.
  • 2 Institute of Neuropathology, University of Zurich, Zurich, Switzerland.
  • 3 Karolinska Institutet, Department of Medicine Solna, Division of Rheumatology, Stockholm, Sweden.
  • 4 Karolinska University Hospital at Solna, Stockholm, Sweden.
  • 5 Institute of Neuropathology, University of Zurich, Zurich, Switzerland. adriano.aguzzi@usz.ch.
Abstract

Oligodendrocyte-lineage cells, including NG2 glia, undergo prominent changes in various neurodegenerative disorders. Here, we identify a neuroprotective role for NG2 glia against prion toxicity. NG2 glia were activated after prion Infection in cerebellar organotypic cultured slices (COCS) and in brains of prion-inoculated mice. In both model systems, depletion of NG2 glia exacerbated prion-induced neurodegeneration and accelerated prion pathology. Loss of NG2 glia enhanced the biosynthesis of prostaglandin E2 (PGE2) by microglia, which augmented prion neurotoxicity through binding to the EP4 receptor. Pharmacological or genetic inhibition of PGE2 biosynthesis attenuated prion-induced neurodegeneration in COCS and mice, reduced the enhanced neurodegeneration in NG2-glia-depleted COCS after prion Infection, and dampened the acceleration of prion disease in NG2-glia-depleted mice. These data unveil a non-cell-autonomous interaction between NG2 glia and microglia in prion disease and suggest that PGE2 signaling may represent an actionable target against prion diseases.

Figures
Products